医学
药物警戒
不利影响
cGMP特异性磷酸二酯酶5型
他达拉非
勃起功能障碍
安全概况
高眼压
药理学
西地那非
重症监护医学
内科学
外科
眼压
作者
Guixiang Chen,Li Zhang,Siting Zhao,Hao Huang,Zhiwen Fu
标识
DOI:10.1080/14740338.2024.2355335
摘要
Background Phosphodiesterase type 5 (PDE5) inhibitors are commonly prescribed for erectile dysfunction and pulmonary hypertension. While PDE5 inhibitors have shown remarkable efficacy in their intended therapeutic areas, there have been concerns regarding their potential ocular adverse events. Our study aims to characterize the ocular safety profiles of PDE5 inhibitors and explore the differences in ocular adverse events among PDE5 inhibitors.
科研通智能强力驱动
Strongly Powered by AbleSci AI